Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac xenotransplantation

V J DiSesa1

  • 1Department of Cardiothoracic Surgery, Allegheny University Hospital, MCP, Philadelphia, Pennsylvania 19129, USA. disesa@auhs.edu

The Annals of Thoracic Surgery
|January 22, 1998
PubMed
Summary

Heart transplantation is limited by donor availability. Cardiac xenotransplantation offers a biologic solution, overcoming immune rejection through genetic engineering and chimerism for future organ availability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term survival of cardiac xenografts in fully xenogeneic (mouse --> rat) bone marrow chimeras.

The Annals of thoracic surgery·2001
Same author

Preventing anti-Gal response in xenograft recipients by an alpha-Gal toxin.

Transplantation proceedings·2001
Same author

As originally published in 1994: Development of tolerance to experimental cardiac allograft in utero. Updated in 2001.

The Annals of thoracic surgery·2001
Same author

Establishment of fully xenogeneic (mouse-->rat) bone marrow chimeras: evidence for normal development and clonal deletion of mouse T cells.

Transplantation·2001
Same author

Extra-anatomic bypass grafting for aortoesophageal fistula: a logical operation.

Journal of vascular surgery·2000
Same author

Avoidance of graft versus host disease by proper titration of cell and radiation dose in a mouse to rat xeno-chimera.

Transplantation proceedings·2000

Area of Science:

  • Cardiovascular Medicine
  • Transplantation Immunology
  • Biotechnology

Background:

  • Heart failure presents a significant medical and public health challenge.
  • Current treatments include medical therapy and mechanical devices, but heart transplantation remains the only definitive solution.
  • The critical shortage of human donor organs severely limits heart transplantation, while mechanical devices face challenges like blood clotting and infection.

Purpose of the Study:

  • To explore cardiac xenotransplantation as a potential biologic solution to the donor organ shortage.
  • To review advancements in overcoming immune rejection barriers in xenotransplantation.
  • To discuss novel strategies involving genetic engineering and bone marrow chimerism for successful xenogeneic organ transplantation.

Main Methods:

  • Utilizing conventional and novel immunosuppressive agents to mitigate immune responses (hyperacute, acute vascular, and cellular rejection).
  • Employing molecular biology tools for genetic engineering of donor animals.
  • Inducing donor and recipient bone marrow chimerism and tolerance in xenogeneic recipients.

Main Results:

  • Significant progress has been made in understanding and addressing the immune response to xenografts.
  • Genetic engineering of donor organs shows promise in reducing immunogenicity.
  • Bone marrow chimerism and tolerance induction are emerging as key strategies for long-term xenograft survival.

Conclusions:

  • Cardiac xenotransplantation is a viable biologic alternative to address the donor organ shortage.
  • Overcoming immune rejection is crucial and achievable through advanced immunosuppression and immunomodulation.
  • A combination of genetically engineered donors and chimeric recipients represents a promising future strategy for successful xenogeneic cardiac transplantation.

Related Experiment Videos